These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire. Kalou M, Sassan-Morokro M, Abouya L, Bile C, Maurice C, Maran M, Tossou O, Roels T, Greenberg AE, Wiktor SZ, Nkengasong JN. J Med Virol; 2005 Feb; 75(2):202-8. PubMed ID: 15602734 [Abstract] [Full Text] [Related]
46. Decline in beta-2 microglobulin levels after antitubercular therapy in tubercular patients with HIV infection. Wanchu A, Arora S, Bhatnagar A, Sud A, Bambery P, Singh S. Indian J Chest Dis Allied Sci; 2001 Feb; 43(4):211-5. PubMed ID: 18610664 [Abstract] [Full Text] [Related]
47. Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection. Aziz N, Nishanian P, Taylor JM, Mitsuyasu RT, Jacobson JM, Dezube BJ, Lederman MM, Detels R, Fahey JL. J Infect Dis; 1999 Apr; 179(4):843-8. PubMed ID: 10068579 [Abstract] [Full Text] [Related]
48. Assessment of human cytomegalovirus specific T cell immunity in human immunodeficiency virus infected patients in different disease stages following HAART and in long-term non-progressors. Tamarit A, Alberola J, Mira JV, Tornero C, Galindo MJ, Navarro D. J Med Virol; 2004 Nov; 74(3):382-9. PubMed ID: 15368523 [Abstract] [Full Text] [Related]
49. Variation in the expression of human immunodeficiency virus RNA and cytokine mRNA in rectal mucosa during the progression of infection. Reka S, Garro ML, Kotler DP. Lymphokine Cytokine Res; 1994 Dec; 13(6):391-8. PubMed ID: 7703312 [Abstract] [Full Text] [Related]
50. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Denny T, Deitch EA. Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411 [Abstract] [Full Text] [Related]
51. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Moore RD, Keruly JC. Clin Infect Dis; 2007 Feb 01; 44(3):441-6. PubMed ID: 17205456 [Abstract] [Full Text] [Related]
52. Characterization of GBV-C infection in HIV-1 infected patients. Canducci F, Uberti Foppa C, Boeri E, Racca S, Gallotta G, Grasso MA, Calori G, Lazzarin A, Clementi M. J Biol Regul Homeost Agents; 2003 Feb 01; 17(2):191-4. PubMed ID: 14518722 [Abstract] [Full Text] [Related]
53. The assessment of IFN-gamma and its regulatory cytokines in the plasma and bronchoalveolar lavage fluid of patients with active pulmonary tuberculosis. Morosini M, Meloni F, Marone Bianco A, Paschetto E, Uccelli M, Pozzi E, Fietta A. Int J Tuberc Lung Dis; 2003 Oct 01; 7(10):994-1000. PubMed ID: 14552571 [Abstract] [Full Text] [Related]
54. Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte count. Mañas E, Pulido F, Peña JM, Rubio R, Gonzalez-García J, Costa R, Pérez-Rodríguez E, Del Palacio A. Int J Tuberc Lung Dis; 2004 Apr 01; 8(4):451-7. PubMed ID: 15141738 [Abstract] [Full Text] [Related]
55. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b. Ochi H, Feng-Jun M, Osoegawa M, Minohara M, Murai H, Taniwaki T, Kira J. J Neurol Sci; 2004 Jul 15; 222(1-2):65-73. PubMed ID: 15240198 [Abstract] [Full Text] [Related]
56. Impact of tuberculosis on serum leptin levels in patients with HIV infection. Prabha C, Karthic S, Das SD, Swaminathan S, Subramaniam S, Sukumar B. Horm Res; 2005 Jul 15; 63(5):228-33. PubMed ID: 15886489 [Abstract] [Full Text] [Related]
57. [The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis]. Tsukaguchi K, Okamura H, Ikuno M, Kobayashi A, Fukuoka A, Takenaka H, Yamamoto C, Tokuyama T, Okamoto Y, Fu A, Yoshikawa M, Yoneda T, Narita N. Kekkaku; 1997 Nov 15; 72(11):617-22. PubMed ID: 9423299 [Abstract] [Full Text] [Related]
58. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients. Bassani S, López M, Toro C, Jiménez V, Sempere JM, Soriano V, Benito JM. Clin Infect Dis; 2007 Jan 01; 44(1):105-10. PubMed ID: 17143825 [Abstract] [Full Text] [Related]
59. [The significance of soluble vascular cell adhesion molecule-1 and its relationship with tumor necrosis factor-alpha and interferon-gamma in patients with pulmonary tuberculosis]. Liang Y, Dong DQ, Yang YH. Zhonghua Jie He He Hu Xi Za Zhi; 2006 Apr 01; 29(4):266-9. PubMed ID: 16750045 [Abstract] [Full Text] [Related]
60. [The clinical significance of changes in CD4+ T cell counts by peripheral blood from patients with pulmonary tuberculosis after antitubercular treatment]. Li DX, Zhang TT, Tan SY, Xiao P, Tan YJ, Zhang XL. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul 01; 26(7):679-81, 684. PubMed ID: 20619093 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]